Ligand Pharma Sells $688K: CFO Stock Sale Spotlight
When a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Which Low Fee Index Funds Offer Best Value 2024 compares low-cost funds to help you pick the best value for retirement goals.
27,292 articlesWhen a company's CFO divests shares amid a strong stock run, investors want to know what it means. This deep dive exp...
Pfizer may be sitting on a hidden GLP-1 opportunity. This article breaks down why the company could prove to be an un...
Salesforce faces leadership questions as founder Marc Benioff approaches three decades at the helm. The company is st...
SpaceX surged on its IPO buzz, then cooled as investors weighed the risk and reward. This guide breaks down what a 30...
CFOs and boards are confronting a pivotal moment: how well they govern AI agents to protect value and manage risk. Th...
Morgan Stanley elevates Rocket Lab's bull-case to $293, underscoring potential upside even as the stock retreats in a...
This article breaks down what to expect from the NESR 2026 earnings call, including key revenue drivers, profitabilit...
Delta Air Lines indicates higher fares could persist even if jet fuel costs ease, citing structural industry shifts a...
Amentum faces a pivotal Q2 2026 earnings season. This deep dive breaks down backlog, margins, and guidance, with prac...
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...
A federal policy shift has just opened new doors for cannabis operators. For Green Thumb Industries and its investors...
Oracle stock down 60% from its peak doesn’t tell the whole story. This article digs into the AI cloud momentum fuelin...